CAD 0.06
(-7.69%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 9.89 Million CAD | 27.3% |
2022 | 7.77 Million CAD | -29.15% |
2021 | 10.97 Million CAD | -50.42% |
2020 | 22.13 Million CAD | -57.0% |
2019 | 51.48 Million CAD | 447.49% |
2018 | 9.4 Million CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 9.85 Million CAD | -0.46% |
2024 Q2 | 9.57 Million CAD | -2.82% |
2023 Q4 | 9.89 Million CAD | -4.79% |
2023 FY | 9.89 Million CAD | 27.3% |
2023 Q2 | 11.32 Million CAD | 39.44% |
2023 Q1 | 8.12 Million CAD | 4.48% |
2023 Q3 | 10.39 Million CAD | -8.22% |
2022 Q2 | 13.56 Million CAD | 14.09% |
2022 Q4 | 7.77 Million CAD | -16.39% |
2022 FY | 7.77 Million CAD | -29.15% |
2022 Q1 | 11.88 Million CAD | 8.3% |
2022 Q3 | 9.3 Million CAD | -31.43% |
2021 Q1 | 24.15 Million CAD | 9.1% |
2021 FY | 10.97 Million CAD | -50.42% |
2021 Q4 | 10.97 Million CAD | -23.73% |
2021 Q3 | 14.39 Million CAD | 5.36% |
2021 Q2 | 13.65 Million CAD | -43.45% |
2020 FY | 22.13 Million CAD | -57.0% |
2020 Q1 | 45.09 Million CAD | -12.42% |
2020 Q2 | 40.32 Million CAD | -10.56% |
2020 Q3 | 31.68 Million CAD | -21.44% |
2020 Q4 | 22.13 Million CAD | -30.12% |
2019 Q2 | 42.42 Million CAD | 92.43% |
2019 FY | 51.48 Million CAD | 447.49% |
2019 Q4 | 51.48 Million CAD | -4.81% |
2019 Q3 | 54.08 Million CAD | 27.49% |
2019 Q1 | 22.04 Million CAD | 134.43% |
2018 Q3 | 7.5 Million CAD | 84.89% |
2018 FY | 9.4 Million CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q2 | 4.06 Million CAD | 0.0% |
2018 Q4 | 9.4 Million CAD | 25.25% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aurora Cannabis Inc. | 186.37 Million CAD | 94.689% |
Avicanna Inc. | 4.54 Million CAD | -117.836% |
Avant Brands Inc. | 28.93 Million CAD | 65.791% |
Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 3636.974% |
Crescita Therapeutics Inc. | 6.12 Million CAD | -61.616% |
Knight Therapeutics Inc. | 91.83 Million CAD | 89.221% |
OrganiGram Holdings Inc. | 80.95 Million CAD | 87.772% |
Canopy Growth Corporation | 77.29 Million CAD | 87.193% |
Willow Biosciences Inc. | 221 Thousand CAD | -4379.186% |
Auxly Cannabis Group Inc. | 31.42 Million CAD | 68.504% |